INS and metabolic dysfunction-associated steatotic liver disease: Common laboratory findings in NAFLD patients are hyperlipidemia, hyperglycemia, decreased insulin sensitivity, and mild or moderate elevations of liver enzymes, specifically, alanine and aspartate aminotransferases (ALT and AST) (9).